A significant price reduction for the E-Eye intense pulsed light (IPL) device, and associated consumables, is expected to make it more affordable for optometrists and ophthalmologists to offer patients long term treatment of dry eye.
The 35 per cent price reduction, announced by E-Eye manufacturer ESW-Vision (formerly E-Swin) reduces the purchase price of the device from AU$39,900 + GST to $25,900 + GST. Consumables have been reduced from $1,360 +GST to $990 + GST.
Aurelien Coursodon, Managing Director of FM Eyecare, which distributes E-Eye in Australia and New Zealand, said he hopes optometrists and ophthalmologists who purchase the device will pass the savings on to patients.
“We want to make the E-Eye as accessible as possible to eye care professionals in Australia and in turn for them to make treatments as affordable as possible for patients. Currently, at around $200 per treatment, we find E-Eye is predominantly used by people who have a high income or chronic dry eye. We believe that if practices can offer patients four treatments for around $500 (as opposed to $800), many more people will benefit from this long term therapy.”
We want to make the E-Eye as accessible as possible to eye care professionals in Australia and in turn for them to make treatments as affordable as possible for patients
Mr Coursodon said optometrists in Australia and New Zealand who have purchased an E-Eye device typically cover their cost of investment within one to two years.
FM Eyecare (formerly France Medical) began distributing E-Eye IPL in Australia and New Zealand in 2014 and today has 200 devices installed with plans to install a further 100 devices in 2019.
“Australia was the first country to begin using the E-Eye technology and since then it has gained increasing acceptance in all countries of Europe as well as China and in South America. While ANZ has the most devices installed globally, China is quickly catching up due to its large population.”
He said following the global success of E-Eye, competitive products have appeared on the market. “We hope that E-Eye’s reputation for safety, efficiency and achieving positive patient results, coupled with a 35 per cent decrease in the cost of the unit and consumables, will ensure our continued success,” said Mr Coursodon.
For information, visit www.fmdistribution.com.au